Cancer treatment is increasingly moving toward therapies that target specific biological mechanisms involved in tumor development and progression. Traditional treatment approaches remain important, but advances in molecular biology have created opportunities for more selective therapeutic strategies. Monoclonal antibodies are an important part of this evolution because they can be designed to...